In a 56‑year‑old woman with iron deficiency anemia (ferritin 18 ng/mL, low serum iron, high total iron‑binding capacity, low transferrin saturation) and normal inflammatory markers, should a colonoscopy be performed?

Yes, colonoscopy is strongly recommended in this patient.

In a 56-year-old postmenopausal woman with confirmed iron deficiency anemia (ferritin 18 ng/mL with classic iron studies), bidirectional endoscopy—including both upper endoscopy (EGD) and colonoscopy—should be performed, preferably at the same setting 1, 2.

Why This Recommendation is Strong

The evidence supporting this recommendation is compelling:

• High malignancy detection rate: In postmenopausal women and men with IDA, colonoscopy detects colorectal cancer in 8.9% and upper GI malignancy in 2.0% of cases 1. This cancer prevalence is approximately 11-fold higher than the 0.8% found in routine colorectal cancer screening populations 1.

• Mortality benefit: High-quality randomized trials demonstrate that endoscopic detection of colorectal cancer reduces both cancer incidence and mortality 1. Early detection in IDA patients offers potential for improved cancer outcomes, particularly given advances in colorectal cancer therapy.

• Multiple treatable conditions: Beyond malignancy, bidirectional endoscopy identifies other important causes including peptic ulcer disease, erosive esophagitis, celiac disease (found in 3-5% of IDA cases), and inflammatory bowel disease 1, 2.

The Diagnostic Approach

Your patient's iron studies confirm true iron deficiency:

• Ferritin 18 ng/mL (well below the diagnostic threshold of <45 ng/mL) 1
• Low serum iron, high TIBC, low transferrin saturation—all consistent with IDA
• Normal inflammatory markers rule out confounding by inflammation

Both upper and lower endoscopy should be performed together because:

1. The diagnostic yield justifies both procedures 1
2. At age 56, she would qualify for colorectal cancer screening regardless of anemia 1
3. The added risk of upper endoscopy is minimal, while the potential benefit is substantial 1

Additional Workup to Consider

Before or concurrent with endoscopy:

• Celiac disease screening (serologic testing or duodenal biopsy during EGD) 2
• Urinalysis to exclude renal blood loss 2
• H. pylori testing (noninvasive or during endoscopy) 3

Common Pitfalls to Avoid

1. Don't delay endoscopy for iron replacement: Start oral iron therapy immediately while arranging endoscopy—don't wait for procedures unless colonoscopy is imminent 2. The exception is that iron therapy may obscure subtle bleeding lesions, so if colonoscopy can be done within days, consider holding iron briefly.

2. Don't assume menstrual blood loss: Even though your patient is 56 and may have perimenopausal bleeding, postmenopausal status (or near-postmenopausal) mandates full GI evaluation 1.

3. Don't use ferritin <15 ng/mL as your threshold: The older threshold of <15 ng/mL has only 59% sensitivity and misses many cases. The evidence-based threshold is <45 ng/mL with 85% sensitivity 1.

Strength of Evidence

This is a strong recommendation based on moderate-quality evidence 1. The AGA 2020 guidelines explicitly state that "most individuals should receive the recommended course of action" and that formal decision aids are not needed 1. The British Society of Gastroenterology 2021 guidelines concur with 100% consensus among guideline developers 2.

The quality rating is moderate (not high) only because direct randomized trials comparing endoscopy versus no endoscopy in IDA don't exist for ethical reasons—but the indirect evidence from observational studies showing high malignancy rates and RCTs demonstrating screening colonoscopy benefits is robust 1.